Research Article
Antiprotozoal and Antimycobacterial Activities of Pure Compounds from Aristolochia elegans Rhizomes
Table 1
Antimycobacterial and antiprotozoal activities of the hexanic extract and pure compounds isolated from A. elegans.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
H37Rv: sensitive strain to INH, RIF, EMB, STR, and pyrazinamide; CIBIN/UMF15:99: resistant strain to INH, RIF, EMB, STR, and pyrazinamide; SIN4: resistant strain to INH, RIF, EMB, STR, rifabutin, ethionamide, and ofloxacin; RIF-R: rifampicin-resistant; STR-R: streptomycin-resistant; INH-R: isoniazid-resistant and EMB-R: ethambutol-resistant. ND: no determined; MIC: minimum inhibitory concentration; IC50: 50% inhibitory concentration. Data are means of three determinations. |